Federal Supply Schedule 36F79724D0210
Award Date
9/29/24
Last Date to Order
9/30/29
Federal Agency
Veterans Integrated Service Network 12
Awardee
Exela Pharma Sciences LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Exela Pharma Sciences LLC, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $3,030,000.00 and a period of performance through September 28, 2024. As a multiple-award schedule contract, this FSS allows the VA and other eligible federal agencies to issue task orders for a wide range of pharmaceutical and drug...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Axsome Therapeutics Inc., provides for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. The $25,000 contract has a period of performance through February 28, 2023. As a multiple award FSS, this contract allows for orders to be placed by any federal agency. The contract does not utilize any set-asides. This interim agreement under the FSS facilitates the...
The Federal Supply Schedule (FSS) contract awarded to Fera Pharmaceuticals, LLC is for the procurement of pharmaceutical drugs, pharmaceuticals, and hematology-related products. The prime contractor, Fera Pharmaceuticals, is a woman-owned small business that supplies the Department of Veterans Affairs (VA) and other government agencies with these products. The FSS contract, valued at up to $450,000.00, was awarded by the VA's Veterans Health Administration Veterans Integrated Service Network...
The Federal Supply Schedule (FSS) contract award, with ID 36F79723D0229, was granted to Legacy Pharma USA, Inc., a foreign-owned, self-certified small disadvantaged business, for the provision of DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS. This multiple-award contract has a ceiling value of $6,150,000.00 and a period of performance ending on September 14, 2028. The contracting agency is the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department...
The Federal Supply Schedule (FSS) contract 36F79720D0115 was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Secura Bio, Inc., a for-profit manufacturer, on April 1, 2020. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) Master Schedule and has a ceiling value of $250,000.00. It is a multiple award contract with no set-asides, and the period of performance runs through September 30, 2025. The purpose of the contract is to provide drugs,...
This Federal Supply Schedule (FSS) contract award to Shield Therapeutics Inc. by the Department of Veterans Affairs (VA) is for the provision of pharmaceutical and drug products under the Pharmaceuticals and Drugs (FSS-61-IB) master GSA schedule. The $225,000 ceiling value contract has a base period of performance through March 14, 2027. As a multiple award schedule, this contract allows the VA and other eligible federal agencies to procure the contracted pharmaceuticals and related hematology...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Scilex Pharmaceuticals Inc., a for-profit organization, on March 1, 2019. The contract has a ceiling value of $300,000.00 and an ultimate completion date of January 31, 2026. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. The contract...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA) to Veloxis Pharmaceuticals, Inc. The contract has a ceiling value of $64,557,260.00 and a period of performance from July 1, 2022 to June 30, 2027. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. As a multiple award contract,...
This Federal Supply Schedule (FSS) contract, awarded by the U.S. Department of Veterans Affairs (VA) to Xlcare Pharmaceuticals Inc., provides a broad range of pharmaceutical products to support the VA's Consolidated Mail Outpatient Pharmacy (CMOP) program and VA medical centers. The multiple-award contract has a period of performance through February 2026 and a ceiling value of $450,000.00. Xlcare Pharmaceuticals, a minority-owned, small disadvantaged business certified as an economically...
This federal contract IDV, awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., is a multiple-award Federal Supply Schedule (FSS) contract for pharmaceutical and drug products under FSS-61-IB. The contract has a ceiling value of $3,077,719,680.00 and a period of performance through September 14, 2025. Exelan Pharmaceuticals, a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida, has been awarded various...